Previous studies in cancer cells have identified hypoxia-associated factor (HAF), that selectively binds and degrades HIF-1α in an oxygen-dependent manner, whereas its binding to HIF-2α selectively increases this factor transactivation [41]. This evidence concerns the gene HIF1A and cancer.